Serum prolidase activity and oxidative–antioxidative status in patients with developmental dysplasia of the hip and its relationship with radiographic severity

References

• Ertürk C, Altay MA, Işikan UE. A radiological comparison of Salter and Pemberton osteotomies to improve acetabular deformations in developmental dysplasia of the hip. J Pediatr Orthop B 2013;22:527–32. doi: 10.1097/BPB.0b013e32836337cd
   PubMed Web of Science ®Google Scholar
• Herring JA. Tachdjian's pediatric orthopaedics. In: Herring JA (ed.), Developmental dysplasia of the hip. Vol. 1. 5th ed. Philadelphia: Elsevier Saunders Company. Chapter 16, 2014. pp. 483–579.
   Google Scholar
• Soran N, Altindag O, Aksoy N, Cakır H, Taşkın A, Soran M, et al. The association of serum prolidase activity with developmental dysplasia of the hip. Rheumatol Int 2013;33(8):1939–42. doi: 10.1007/s00296-013-2672-9
   PubMed Web of Science ®Google Scholar
• Altay MA, Erturk C, Aksoy N, Taskın A, Isıkan UE. A preliminary study pointing out the role of serum prolidase activity and oxidative-antioxidative status parameters during the treatment process of patients with idiopathic clubfoot. Scand J Clin Lab Invest 2011;71(7):576–82. doi: 10.3109/00365513.2011.596661
   PubMed Web of Science ®Google Scholar
• Altindag O, Erel O, Aksoy N, Selek S, Celik H, Karaoglanoglu M. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int 2007;27:339–44. doi: 10.1007/s00296-006-0247-8
   PubMed Web of Science ®Google Scholar
• Evrenkaya TR, Atasoyu EM, Kara M, Unver S, Gultepe M. The role of prolidase activity in the diagnosis of uremic bone disease. Ren Fail 2006;28:271–4. doi: 10.1080/08860220600577726
   PubMed Web of Science ®Google Scholar
• Galicka A, Nazaruk J. Stimulation of collagen biosynthesis by flavonoid glycosides in skin fibroblasts of osteogenesis imperfecta type I and the potential mechanism of their action. Int J Mol Med 2007;20(6):889–95.
   PubMed Web of Science ®Google Scholar
• Altay MA, Erturk C, Aksoy N, Taskin A, Bilge A, Celik H, et al. Serum prolidase activity and oxidative-antioxidative status in Legg-Calve-Perthes disease. J Pediatr Orthop B 2011;20(4):222–6. doi: 10.1097/BPB.0b013e32834493df
   PubMed Web of Science ®Google Scholar
• Ertürk C, Altay MA, Selek S, Koçyiğit A. Paraoxonase-1 activity and oxidative status in patients with knee osteoarthritis and their relationship with radiological and clinical parameters. Scand J Clin Lab Invest 2012;72(5):433–9. doi: 10.3109/00365513.2012.687116
   PubMed Web of Science ®Google Scholar
• Rahman T, Hosen I, Islam MMT, Shekhar HU. Oxidative stress and human health. Adv Biosci Biotechnol 2012;3:997–1019. doi: 10.4236/abb.2012.327123
   Google Scholar
• Ertürk C, Altay MA, Yarimpapuç R, Koruk I, Işikan UE. One-stage treatment of developmental dysplasia of the hip in untreated children from two to five years old. A comparative study. Acta Orthop Belg 2011;77(4):464–71.
   PubMed Web of Science ®Google Scholar
• Donnelly KJ, Chan KW, Cosgrove AP. Delayed diagnosis of developmental dysplasia of the hip in Northern Ireland: can we do better? Bone Joint J 2015;97-B(11):1572–6. doi: 10.1302/0301-620X.97B11.35286
   PubMed Web of Science ®Google Scholar
• Ozcan O, Gultepe M, Ipcioglu O, Bolat B, Kayadibi H. Optimization of the photometric enzyme activity assay for evaluating real activity of prolidase. Turk J Biochem 2007;32:12–16.
   Web of Science ®Google Scholar
• Ekin S, Arısoy A, Gunbatar H, Sertogullarindan B, Sunnetcioglu A, Sezen H, et al. The relationships among the levels of oxidative and antioxidative parameters, FEV1 and prolidase activity in COPD. Redox Rep 2016 15:1–4. [Epub ahead of print].
   Google Scholar
• Yildiz A, Demirbag R, Yilmaz R, Gur M, Altiparmak IH, Akyol S, et al. The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis 2008;19:319–25. doi: 10.1097/MCA.0b013e32830042ba
   PubMed Web of Science ®Google Scholar
• Demirkol A, Uludag M, Soran N, Aksoy N, Gun K, Incebıyık S, et al. Total oxidative stress and antioxidant status in patients with carpal tunnel syndrome. Redox Rep 2012;17:234–8. doi: 10.1179/1351000212Y.0000000027
   PubMed Web of Science ®Google Scholar
• Hilali N, Aksoy N, Vural M, Camuzcuoglu H, Taskin A. Oxidative status and serum prolidase activity in tubal ectopic pregnancy. J Pak Med Assoc 2013;63(2):169–72.
   PubMed Web of Science ®Google Scholar
• Poljsak B, Šuput D, Milisav I. Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants. Oxid Med Cell Longev 2013;2013:956792. doi: 10.1155/2013/956792
   PubMed Web of Science ®Google Scholar
• Li Y, Xu H, Li J, Yu L, Liu Y, Southern E, et al. Early predictors of acetabular growth after closed reduction in late detected developmental dysplasia of the hip. J Pediatr Orthop B 2015;24(1):35–39. doi: 10.1097/BPB.0000000000000111
   PubMed Web of Science ®Google Scholar
• Eberhardt O, Wirth T, Fernandez FF. Arthroscopic anatomy of the dislocated hip in infants and obstacles preventing reduction. Arthroscopy 2015;31(6):1052–9. doi: 10.1016/j.arthro.2014.12.019
   PubMed Web of Science ®Google Scholar
• Rhodes AM, Clarke NM. A review of environmental factors implicated in human developmental dysplasia of the hip. J Child Orthop 2014;8(5):375–9. doi: 10.1007/s11832-014-0615-y
   PubMedGoogle Scholar
• Staheli LT. Fundamentals of pediatric orthopedics. In: Staheli LT (ed.), Hip and femur. 4th ed. Philadelphia: Wolters Kluwer Health. Chapter 11, 2008. pp. 201–30.
   Google Scholar
• Shi D, Dai J, Zhu P, Qin J, Zhu L, Zhu H, et al. Association of the D repeat polymorphism in the ASPN gene with developmental dysplasia of the hip: a case-control study in Han Chinese. Arthritis Res Ther 2011;13:R27. doi: 10.1186/ar3252
   PubMed Web of Science ®Google Scholar
• Gold SL, Burge AJ, Potter HG. MRI of hip cartilage: joint morphology, structure, and composition. Clin Orthop Relat Res 2012;470:3321–31. doi: 10.1007/s11999-012-2403-7
   PubMed Web of Science ®Google Scholar
• Loder RT, Skopelja EN. The epidemiology and demographics of hip dysplasia. ISRN Orthop 2011; 2011:238607.
   PubMedGoogle Scholar
• Zhao L, Tian W, Pan H, Zhu X, Wang J, Cheng Z, et al. Variations of the COL1A1 gene promoter and the relation to developmental dysplasia of the hip. Genet Test Mol Biomarkers 2013;17(11):840–3. doi: 10.1089/gtmb.2013.0179
   PubMed Web of Science ®Google Scholar
• Blatt SH. To swaddle, or not to swaddle? Paleoepidemiology of developmental dysplasia of the hip and the swaddling dilemma among the indigenous populations of North America. Am J Hum Biol 2015;27(1):116–28. doi: 10.1002/ajhb.22622
   PubMed Web of Science ®Google Scholar
• Karakoc M, Altindag O, Keles H, Soran N, Selek S. Serum oxidative-antioxidative status in patients with ankylosing spondylitis. Rheumatol Int 2007;27:1131–4. doi: 10.1007/s00296-007-0352-3
   PubMed Web of Science ®Google Scholar